01.01.07
AMINO, Frellstedt, Germany, has completed a leveraged management buyout of the amino acids business of AMINO GmbH. Under the terms of the buyout, the new AMINO team, led by managing director Dr. Lutz Thomas, and supported by new private investors, will acquire the amino acids business together with the main assets of the former AMINO GmbH. These include its production site in Frellstedt and the jobs at this location, thus making the new AMINO one of the few amino acid manufacturers in Europe. AMINO will focus completely on pharma- and infusion-grade amino acids produced under strict cGMP standards and developed from both extraction (concentrating on vegetable raw materials) technology and modern biotechnology/fermentation.